Read some of the latest prostate cancer NEWS You Can Use from Us TOO

Prostate Cancer News You Can Use from Us TOO provides some of the latest news articles on prostate cancer and is distributed via email each month at no charge.

Subscribe to get Prostate Cancer News You Can Use (and other news and information) for free via email from Us TOO at www.ustoo.org/subscribe.

Made possible by a charitable contribution from




Opt-In
to receive prostate cancer news articles from Us TOO


Lantheus Receives U.S. FDA Approval of PYLARIFY® (piflufolastat F 18) Injection, the First and Only Commercially Available PSMA PET Imaging Agent for Prostate Cancer

PYLARIFY will be available immediately to imaging centers in parts of the mid-Atlantic and southern regions and is expected to be broadly available throughout the U.S. by year end

Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI® for the Treatment of Advanced Prostate Cancer; Accord BioPharma to Head the U.S. Commercialization

TAIPEI, May 26, 2021 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug

CLEVELAND CLINIC RESEARCHERS IDENTIFY NEW DRUG TARGET FOR TREATING AGGRESSIVE PROSTATE CANCER

The following information was released by the Cleveland Clinic: Content is property of Cleveland Clinic and for news media use only. According to new findings published in Science

Environmental quality linked to advanced-stage prostate cancer at diagnosis

Chicago [US], May 23 (ANI): According to a new study by University of Illinois Chicago researchers, environmental quality is associated with advanced-stage prostate cancer at

Decrease in prostate cancer diagnoses due to pandemic

2021 MAY 19 (NewsRx) -- By a News Reporter-Staff News Editor at TB & Outbreaks Daily News -- During the first wave of the corona pandemic, 36 per cent fewer men were diagnosed with

Case Western Reserve: First Clinical Trials Set for MRI Cancer Detection

CLEVELAND, Ohio, April 23 (TNSRes) -- Case Western Reserve University issued the following news release:The U.S. Food and Drug Administration has approved human clinical trials to

Men with low health literacy less likely to choose active surveillance for prostate cancer after tumor profiling

2021 APR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Education Daily Report -- Tumor gene profiling is a tool that can help patients with a cancer diagnosis make

New treatment for ED after prostate surgery being developed, researchers say

Men undergoing surgery for prostate cancer may no longer have to live with erectile dysfunction afterward, thanks to an innovative new treatment, researchers said in a paper

CTC mutations may predict outcomes in some castrate-resistant prostate cancer patients

2021 APR 14 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Drug Daily -- Bottom Line: Various genetic alterations in circulating tumor cells (CTCs) were associated with

$36 Million Available in Grants/Cooperative Agreements for Prostate Cancer Research

WASHINGTON, April 7 -- The U.S. Army Medical Research Acquisition Activity announced that it expects to award up to 30 grants or cooperative agreements for prostate cancer research


Receive emails from Us TOO including the HotSheet e-newsletter and the latest Prostate Cancer News You Can Use each month.

Subscribe to the news feed and emails from Us TOO.

Click here to Subscribe